GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline (GSK) is conducting a Phase 3 ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

A pharmaceutical factory which ceased production earlier this year has been bought by Britain's biggest defence firm. BAE ...

Part of a pharmaceutical factory which opened more than 75 years ago will be demolished. GSK plc (formerly GlaxoSmithKline) ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 3.1% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up ...

The plans, lodged by pharmaceutical giant GSK plc (formerly GlaxoSmithKline), asked permission to destroy a single manufacturing building along with several associated tanks, pipe bridges, cooling ...

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today at ...

CNW/ - Dalhousie University, in collaboration with Nova Scotia Health's INSPIRED COPD Outreach Program, the Nova Scotia ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 10.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...